CDK1/Cyc B-IN-1

Modify Date: 2024-01-28 16:46:12

CDK1/Cyc B-IN-1 Structure
CDK1/Cyc B-IN-1 structure
Common Name CDK1/Cyc B-IN-1
CAS Number 2459916-56-2 Molecular Weight 353.85
Density N/A Boiling Point N/A
Molecular Formula C14H12ClN3O2S2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CDK1/Cyc B-IN-1


CDK1/Cyc B-IN-1 (Compound 5) is a selective CDK1/Cyc B complex inhibitor with an IC50 of 97 nM. CDK1/Cyc B-IN-1 triggers apoptosis and G2/M cell cycle arrest. CDK1/Cyc B-IN-1 shows broad-spectrum cytotoxic action against cancer cell lines[1].

 Names

Name CDK1/Cyc B-IN-1

 CDK1/Cyc B-IN-1 Biological Activity

Description CDK1/Cyc B-IN-1 (Compound 5) is a selective CDK1/Cyc B complex inhibitor with an IC50 of 97 nM. CDK1/Cyc B-IN-1 triggers apoptosis and G2/M cell cycle arrest. CDK1/Cyc B-IN-1 shows broad-spectrum cytotoxic action against cancer cell lines[1].
Related Catalog
Target

CDK1-Cyclin B:97 nM (IC50)

In Vitro CDK1/Cyc B-IN-1 (Compound 5) shows cytotoxic activity with IC50 values of 5.33 ± 0.69 µM and 21.69 ± 1.04 µM against HCT-116 and WI-38, respectively[1].
References

[1]. Mohamed SH, et al. An investigative study of antitumor properties of a novel thiazolo[4,5-d]pyrimidine small molecule revealing superior antitumor activity with CDK1 selectivity and potent pro-apoptotic properties. Bioorg Med Chem. 2020 Sep 1;28(17):115633.

 Chemical & Physical Properties

Molecular Formula C14H12ClN3O2S2
Molecular Weight 353.85
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.